Nanomedicine By People For People
The purpose of healthcare research in humans is to improve the care of patients at all stages of disease. Clinical trials are a key step in the process of developing a healthcare product. They aim to establish and evaluate the safety and efficacy of new treatments.
Clinical trials are designed and managed according to strict scientific, legal, regulatory and methodological standards, and are governed by medical ethics. Clinical trials follow after preclinical “in vitro” and “in vivo” studies have been completed, and can only be initiated after authorization from health authorities and regulatory bodies, which are closely involved in clinical trial design.
Heath authorities deliver market authorization to each healthcare product. The results of clinical trials provide the basis for the healthcare product to become registered.
To access further information on our clinical trials, please consult the global record of clinical studies: www.clinicaltrials.gov (If you follow this link you will leave the Nanobiotix website and be redirected to www.clinicaltrials.gov)